Brief Introduction

Eyebright Medical Technology (Beijing) Co., Ltd., a SSE STAR market listed company (688050.SH), is a National High-tech Enterprise located in Zhongguancun Science and Technology Park of Beijing, China. We focus on the protection and cares of human eyes and vision health, with aiming to provide first-class medical products and services to global ophthalmology surgeons, patients and consumers.

Eyebright Medical has been developing a full range of ophthalmic medical products, which include surgical implants, surgical instruments, equipments, optometric lenses, eye drops etc., for the treatment of cataract, glaucoma, refractive errors and many other ophthalmic diseases.

Eyebright Medical is committed to the mission of developing innovative new technologies and products. As a Joint Laboratory of National Engineering Research Center for Ophthalmic Equipment in China, we own the most advanced R&D facilities and equipments, and form a multi-disciplinary professional team including engineers and scientists from material, optical, mechanical and clinical research fields. Eyebright Medical has applied for more than 180 patents worldwide. Around 100 patents are awarded upon our dedicated research work, among which have been granted by The United States, Europe, Japan, Korea, Singapore and Hongkong.

Eyebright Medical illuminates your world.

Company Overview

Full name Eyebright Medical Technology (Beijing) Co., Ltd.
Abbreviations Eyebright Medical
Code 688050
Founded 2010.04.21
Listing 2020.07.29
Domicile Changping Beijing
STAR Theme Biomedicine
CSRCSector Manufacturing
Has weighted voting rights structure? NONE



  2019 2018 2017
Earnings Per Share 0.85 0.28 -0.06
R&D expenditure as a % of operating revenue 14.68% 15.51% 21.87%
Operating Revenue 195.20 126.97 74.81
Net Income 65.76 20.31 -4.11

Income Statement (Unit: RMB mn)

  2019 2018 2017
Operating Revenue 195.20 126.97 74.81
Operating Costs 27.94 23.66 18.62
Operating Income 69.66 26.75 -3.16
Pretax Income 69.66 26.71 -3.14
Income Tax 3.90 6.41 0.96
Net Income 65.76 20.31 -4.11

Balance Sheet(Unit: RMB mn)

  2019 2018 2017
Current Assets-Total 334.52 361.54 95.83
Non-current Assets-Total 351.27 224.92 180.23
Total Assets 685.78 586.45 276.06
Current Liabilities-Total 23.13 23.97 37.96
Non-current Liabilities-Total 15.13 8.62 39.66
Total Liabilities 38.26 32.59 77.62
Stockholder's Equity
Share Capital 606.38 559.92 227.81
Retained Profits 11.18 -9.05 -29.37
Minority Interests 29.97 3.00  
Total Owners' Equity 647.52 553.87 198.44

Cash Flow Statement (Unit: RMB mn)

  2019 2018 2017
Net Cash Flows-Operating 50.49 31.82 4.15
Net Cash Flows-Investing 63.98 -272.21 -33.57
Net Cash Flows-Financing 14.90 276.42 18.48

Top 10 Shareholders

Name No. of Shares Held (mn) % of Shares Held
解江冰XIE Jiangbing 13.59 12.93%
富达成长(上海)股权投资合伙企业(有限合伙) Fidelity Growth (Shanghai) Equity Investment Partnership (L.P.) 7.27 6.92%
白莹BAI Ying 6.76 6.43%
北京博健和创科技有限公司 (无英文名称) 6.07 5.77%
宁波梅山保税港区博健创智投资合伙企业(有限合伙) (无英文名称) 4.30 4.09%
世纪阳光控股集团有限公司 CENTURY SUNSHINE GROUP 4.00 3.80%
北京龙磐生物医药创业投资中心(有限合伙) Beijing Longpan Biological Medicine Venture Capital Center(L.P.) 4.00 3.80%
上海诺毅投资管理有限公司 Shanghai Nuoyi Investment Management Co., Ltd 3.93 3.74%
毛立平MAO Liping 3.11 2.96%
北京启迪日新创业投资有限公司 Beijing TusPark Rixin Venture Capital Co., Ltd. 3.05 2.90%
30 Sep 2020

Legal Statement

All information contained herein is provided by the underlying company itself and is for informational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. The Shanghai Stock Exchange does not guarantee its accuracy and reliability and shall under no circumstance be responsible or liable for any error or for any loss directly or indirectly arising from any inaccuracy or omission or from any decision, action or non-action based on or in reliance upon the information herein.

Users may view and download the information herein for personal and non-commercial use free of charge subject to the laws of the People's Republic of China and the Legal Statement. No part of the information herein may be copied, downloaded, stored in a retrieval system or transmitted in any form or by any means, rented, displayed, performed, reproduced, photocopied, altered, sold, broadcast, published or otherwise in whole or in part in any manner for commercial purposes, without the prior written consent of the Shanghai Stock Exchange.

Users are hereby reminded that the Legal Statement represents your legally binding agreement with the Shanghai Stock Exchange. By accessing or using this website, you are also signifying your agreement with and acceptance of all the contents in the Legal Statement. The Shanghai Stock Exchange reserves the right to amend and interpret the Legal Statement.